Prokidney Corp Stock Price To Earnings To Growth
| PROK Stock | USD 3.18 0.08 2.45% |
ProKidney Corp's fundamental analysis aims to assess its intrinsic value by examining key economic and financial indicators - such as cash flow records, changes in balance sheet accounts, income statement trends, financial ratios, and relevant microeconomic factors affecting ProKidney Stock price.
ProKidney | Build AI portfolio with ProKidney Stock |
ProKidney Corp Company Price To Earnings To Growth Analysis
ProKidney Corp's PEG Ratio indicates the potential value of an equity instrument and is calculated by dividing Price to Earnings (P/E) ratio into earnings growth rate. Most analysts and investors prefer this measure to a Price to Earnings (P/E) ratio because it incorporates the future growth of a firm. The low PEG ratio usually implies that an equity instrument is undervalued; whereas PEG of 1 may indicate that an equity is reasonably priced under given expectations of future growth.
Generally speaking, PEG ratio is a 'quick and dirty' way to measure how the current price of a firm's stock relates to its earnings and growth rate. The main benefit of using PEG ratio is that investors can compare the relative valuations of companies within different industries without analyzing their P/E ratios.
| Competition |
Based on the latest financial disclosure, ProKidney Corp has a Price To Earnings To Growth of 0.0 times. This is 100.0% lower than that of the Biotechnology sector and 100.0% lower than that of the Health Care industry. The price to earnings to growth for all United States stocks is 100.0% higher than that of the company.
Did you try this?
Run Headlines Timeline Now
Headlines TimelineStay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |
| All Next | Launch Module |
ProKidney Fundamentals
| Return On Equity | -0.45 | ||||
| Return On Asset | -0.28 | ||||
| Operating Margin | (179.95) % | ||||
| Current Valuation | 109.82 M | ||||
| Shares Outstanding | 133.42 M | ||||
| Shares Owned By Insiders | 30.05 % | ||||
| Shares Owned By Institutions | 42.30 % | ||||
| Number Of Shares Shorted | 11.41 M | ||||
| Price To Book | 97.15 X | ||||
| Price To Sales | 5,921 X | ||||
| Revenue | 76 K | ||||
| Gross Profit | 306 K | ||||
| EBITDA | (158.49 M) | ||||
| Net Income | (163.34 M) | ||||
| Cash And Equivalents | 21.88 M | ||||
| Cash Per Share | 0.36 X | ||||
| Total Debt | 3.24 M | ||||
| Debt To Equity | 5.66 % | ||||
| Current Ratio | 0.74 X | ||||
| Book Value Per Share | (7.71) X | ||||
| Cash Flow From Operations | (126.35 M) | ||||
| Short Ratio | 0.31 X | ||||
| Earnings Per Share | (0.68) X | ||||
| Target Price | 5.6 | ||||
| Number Of Employees | 204 | ||||
| Beta | 1.81 | ||||
| Market Capitalization | 1.81 B | ||||
| Total Asset | 441.07 M | ||||
| Retained Earnings | (1.2 B) | ||||
| Working Capital | 359.67 M | ||||
| Net Asset | 441.07 M |
About ProKidney Corp Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze ProKidney Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of ProKidney Corp using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of ProKidney Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ProphetCheck out ProKidney Corp Piotroski F Score and ProKidney Corp Altman Z Score analysis. For more information on how to buy ProKidney Stock please use our How to buy in ProKidney Stock guide.You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Is Pharmaceutical Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ProKidney Corp. If investors know ProKidney will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ProKidney Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of ProKidney Corp is measured differently than its book value, which is the value of ProKidney that is recorded on the company's balance sheet. Investors also form their own opinion of ProKidney Corp's value that differs from its market value or its book value, called intrinsic value, which is ProKidney Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ProKidney Corp's market value can be influenced by many factors that don't directly affect ProKidney Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ProKidney Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if ProKidney Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ProKidney Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.